Patent Assignment
Reel/Frame 062725/0474
Assignment of Assignor's Interest
Recorded: 2023-02-16
Pages: 4
Assignor
ADIMAB, LLC
Executed: 2022-04-12
Assignee
MAGENTA THERAPEUTICS, INC.
100 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Methods of Use of Anti-CD45 Antibodies and Conjugates Thereof
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 16, 2023
From: BOITANO, ANTHONY; COOKE, MICHAEL; MCDONAGH, CHARLOTTE; PALCHAUDHURI, RAHUL
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 062725/0415 →
Assignment of Assignor's Interest
Feb 16, 2023
From: PANWAR, RAJIV
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 062725/0424 →
Assignment of Assignor's Interest
Feb 16, 2023
From: WIDBOOM, PAUL FREDRICK; CRUITE, PATRICIA ANN
To: ADIMAB, LLC
Reel/Frame 062725/0464 →
Assignment of Assignor's Interest
May 28, 2024
From: MAGENTA THERAPEUTICS, INC.
To: VOR BIOPHARMA INC.
Reel/Frame 067535/0539 →
Corrective Assignment to Correct the Typographical Error in the Coversheet Regarding the Spelling of the Assignee's Name. Previously Recorded on Reel 67535 Frame 539. Assignor(S) Hereby Confirms the Assignment.
Nov 26, 2025
From: MAGENTA THERAPEUTICS, INC.
To: VOR BIOPHARMA, INC.
Reel/Frame 073782/0461 →
Assignment of Assignor's Interest
Dec 22, 2025
From: VOR BIOPHARMA, INC.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 074028/0972 →